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This paper presents evidence-based results of clinical trial on the use of nanosized particles in homoeopathic
Terminalia arjuna tincture. Dynamic light scattering technique demonstrates that homoeopathic tincture is a
mixture of particles varying from micron to nanometre sizes. The process of succussion, homogenization and
filtration brings down the particles of source material to nanosize as a ‘top-down’ process. As compared to the
conventionally used micron-sized T. arjuna powder, the results show significant clinical improvement due to the
presence of nanoparticles in tincture by the above method. Similar results were reconfirmed on experiments with
bacterial cultures. From clinical trials, it has been confirmed that the dose of medicine required by the patient is
significantly reduced with the reduction in particle size. No toxicity was observed even after giving medicine for
more than 8 weeks. Size-dependent sensitivity of the drug can help to tackle the problem of drug resistance in
bacteria.
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Holarrhena antidysenterica is a tropical plant which
grows up to 5 m in height. The bark extract of this plant
is used in ayurvedic and homoeopathic systems of medi-
cine for the treatment of tropical diarrhoeas and dysen-
tery. It belongs to Apocynaceae family. Around 30
alkaloids have been isolated from the plant, mostly from
the bark. These include conessine, kurchine, kurchicine,
holarrhimine, conarrhimine, conaine, conessimine, iso-
conessimine, conimine, holacetin and conkurchin [1]. It
is a well-known drug for amoebic dysentery and other
gastric disorders. It is also indicated for the treatment of
diarrhoea, indigestion, flatulence and colic [2]. Hom-
oeopathic system of medicine uses ethanolic extracts,
called as mother tincture, and their dilutions (poten-
cies). As per the Homoeopathic Pharmacopoeia of India
standard, the drug strength is 1/10. Since there is no
standardization criterion for the particle size of the tinc-
ture, the experimentation was carried out by changing
the particle size of the tincture, and size-related effects
were compared in vitro.* Correspondence: rsctifr@yahoo.com
2Department of Chemistry, Ramnarain Ruia College, Matunga, Mumbai
400019, India
Full list of author information is available at the end of the article
© 2013 Barve and Chaughule; licensee Springe
Commons Attribution License (http://creativeco
reproduction in any medium, provided the origTerminalia arjuna is known over 2,000 years as good
cardioprotective medicine. Many useful phytoconstituents
have been isolated from T. arjuna which includes
triterpenoids for cardiovascular properties, tannins and
flavonoids for its anticancer properties and so on. The
bark leaves and fruits of T. arjuna have been used in the
indigenous system of medicine for different ailments [3].
The bark contains a very high level of flavonoids com-
pared to other commonly used plant items. Flavonoids
detected from its bark are arjunolone, flavones, bicalein,
quercetin, kempferol and pelorgonidin [4-6]. Traditionally
in ayurvedic medicine, T. arjuna powder with a dose of 1
to 2 g/day and an average powder size of about 50 μm is
used for the patients. T. arjuna is also known to reduce
lipid levels. This was verified by in vivo studies on 32
hyperlipidemic patients by giving them this mother tinc-
ture which has much lesser particle size.
Results and discussions
Table 1 shows the results of ten patients who took
T. arjuna dose of 0.083 g for 8 weeks or more. The pa-
tients showed significant reduction in low-density lipo-
protein (LDL), very low-density lipoprotein (VLDL),
triglyceride (TG) and total cholesterol as compared to
the traditional dose of 1 to 2 g/day of T. arjuna powderr. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Table 1 In vivo experiment of T. arjuna tincture for certain


















1 27 36 35 45 46
5 25.8 - 41.8 19 18.9
8 37 50 30 - 23.2
11 42 21 37 - 5.2
13 23 5 26.1 24.2 23.9
20 28 7.1 39 10 31.5
25 15.6 14.2 25.2 50 46.9
27 13.8 33.3 24.8 41.6 41.6
29 25.4 21 46.2 33.3 12.2
30 17.7 4.6 11.1 42.3 48.7
Figure 2 E. coli 10536 culture with Holarrhena tincture of 2.67-
μm size (1 and 3), alcohol (2) and blank disc (Std).
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ket. There is also an increase in high-density lipopro-
tein (HDL) levels by about 20% which is hardly seen in
any other anti-lipid drug as HDL is cardioprotective.
Figure 1 represents Escherichia coli M200 culture with
2.67-μm particle size of Holarrhena tincture on LHS plate
showing no zone of inhibition. However, with 13.8-nm
particle size of the same tincture on RHS plate, E. coli
M200 gives 10 mm of zone inhibition. Figure 2 repre-
sents E. coli 10536 culture with Holarrhena tincture of
particle size 2.67 μm, and Figure 3 shows E. coli 10536
culture with Holarrhena tincture having particle size
of 13.8 nm.
Conclusions
This study clearly demonstrates particle size-dependent
variation in the drug action. Reduction in the particle
size of the drug improves the sensitivity of the drug as
seen in in vivo experiment of T. arjuna drug. Reduction
of particle size from 50 μm to 23 nm showed drastic re-
duction in dose requirement, i.e. from 1 to 2 g/day to
0.083 g/day. No toxicity was observed with this
nanodose even after giving for 2 months or more.Figure 1 E. coli M200 culture with Holarrhena tincture of 2.67
μm and 13.8 nm in size.From in vitro experiments with E. coli, it is clear
that reduction of particle size of tincture improved
the culture results by 15% or more. Interestingly, E. coli
M200 showed resistance to Holarrhena tincture at 2.67-μm
particle size but showed sensitivity at 13.8-nm particle size
tincture. This phenomenon is reported for the first time
and can help to reduce drug resistance problem for the pa-
tients in the future.
Methods
T. arjuna tincture manufactured by Bakson, India was
used for in vivo clinical trials using the dynamic light
scattering (DLS) system of Aimil Malvern Instruments
from Baroda. Its mean particle size was 23 nm
(Figure 4). Holarrhena tincture also manufactured by
Bakson, India was used for bacterial studies. The
particle size determined by DLS was found to be 2.67
μm (Figure 5). Further reduction in particle size of this
tincture to 13.8 nm (Figure 6) was achieved by standard
succussion, homogenization and filtration methods.
Four pathogenic strains of E. coli (11100, 11105,
10536, M200) were collected and inoculated in
culture plates (Table 2). Nutrient agar was used as
culture media. Sterile Whatman paper discs of 5-
mm-diameter size were impregnated with 0.1 ml
Holarrhena antidysenterica tincture with particle
sizes of 2.67 μm and 13.8 nm, respectively. DiscsFigure 3 E. coli 10536 culture with Holarrhena tincture of 13.8-
nm size (1 and 3), alcohol (2) and blank disc (Std).
Figure 4 Intensity distribution of arjuna nanoparticles using dynamic light scattering (DLS) system.
Figure 5 Holarrhena tincture particle size (2.67 μm) using DLS method.
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Figure 6 Reduction of Holarrhena tincture particle size (13.8 nm).
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cultures. The disc with 0.1 ml ethanol was kept as a
control since tinctures contain 60% ethanol. Culture
plates were incubated at 32°C for 36 h to get good
bacterial colonies. Finally, zones of inhibitions were
measured and compared to know the efficacy of the
drug and effect of particle sizes (Figures 1, 2, 3).
All 32 hyperlipidemic patients, who were not taking
any anti-lipid medicines, were randomly selected. Their
vital data regarding lipid levels, diet, habits, type of
work, stress level and history of present- and past-
associated illnesses were noted. Every patient was
given oral dose of 10 drops of T. arjuna tincture with
water at bedtime. The calculated weight of this 23-nm
particle size tincture dose is 0.083 g. Dose was given
for 8 weeks and more to compare the changes in lipid
levels (Table 1).Table 2 E. coli and H. antidysenterica tincture
Holarrhena tincture zone of inhibition (mm)
2.67 μm 13.8 nm
E. coli M200 No zone 10
E. coli 10536 24 26
E. coli 11105 22 25
E. coli 11100 24 25Competing interests
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